Tokyo, Japan

Toshifumi Tatsumi

This inventor holds 2 USPTO granted patents and 9 published patent applications. Top assignees: The University of Tokyo, Complecure, Inc., Savid Therapeutics Inc.. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshifumi Tatsumi. Retrieved from https://idiyas.com/inventor/toshifumi-tatsumi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Toshifumi Tatsumi: Innovator in Photoimmunotherapy

Introduction

Toshifumi Tatsumi is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of photoimmunotherapy through his innovative research and development.

Latest Patents

Tatsumi holds a patent for a conjugate of a biotin-modified dimer and a phthalocyanine dye. This invention aims to provide a conjugate that is utilized in photoimmunotherapy. The compound is represented by a specific formula, which enhances its application in medical treatments.

Career Highlights

Throughout his career, Toshifumi Tatsumi has worked with prestigious institutions, including the University of Tokyo and Savid Therapeutics Inc. His work has been instrumental in advancing the understanding and application of photoimmunotherapy.

Collaborations

Tatsumi has collaborated with notable colleagues such as Motomu Kanai and Kenzo Yamatsugu. Their combined expertise has contributed to the success of various projects in the field.

Conclusion

Toshifumi Tatsumi's innovative work in photoimmunotherapy highlights his role as a key inventor in the medical field. His contributions continue to influence advancements in therapeutic techniques.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…